These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8015813)

  • 1. [Zn-content of erythrocytes in overt and subclinical hyperthyroidism].
    Varga F; Tarján G; Steczek K; Földes J
    Orv Hetil; 1994 May; 135(22):1183-5. PubMed ID: 8015813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Erythrocyte carbonic anhydrase I and zinc concentrations in thyrotoxicosis reflect integrated thyroid hormone levels over the previous few months].
    Yoshida K
    Rinsho Byori; 2007 Jun; 55(6):560-5. PubMed ID: 17657991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical and therapeutic approach to thyrotoxicosis with thyroid-stimulating hormone suppression only.
    Papi G; Pearce EN; Braverman LE; Betterle C; Roti E
    Am J Med; 2005 Apr; 118(4):349-61. PubMed ID: 15808130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum sex hormone-binding globulin levels in thyroid diseases].
    Földes J; Bános C; Lakatos P; Tarján G
    Orv Hetil; 1990 Jul; 131(29):1579-82. PubMed ID: 2392320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical hyperthyroidism as a risk factor for atrial fibrillation.
    Auer J; Scheibner P; Mische T; Langsteger W; Eber O; Eber B
    Am Heart J; 2001 Nov; 142(5):838-42. PubMed ID: 11685172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in zinc level in the serum, whole blood and erythrocytes in disorders of thyroid function].
    Buchinger W; Leopold B; Lind P; Langsteger W; Klima G; Költringer P; Wawschinek O; Eber O
    Wien Klin Wochenschr; 1988 Sep; 100(18):619-21. PubMed ID: 3188537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of zinc supplementation on the zinc level in serum and urine and their relation to thyroid hormone profile in male and female goitrous patients.
    Kandhro GA; Kazi TG; Afridi HI; Kazi N; Baig JA; Arain MB; Sirajuddin ; Shah AQ; Sarfraz RA; Jamali MK; Syed N
    Clin Nutr; 2009 Apr; 28(2):162-8. PubMed ID: 19250719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated free triiodothyronine: an uncommon form of hyperthyroidism.
    Goldman MH
    N J Med; 1995 Aug; 92(8):516-7. PubMed ID: 7675333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium, magnesium, and zinc status in experimental hyperthyroidism.
    Simsek G; Andican G; Unal E; Hatemi H; Yigit G; Candan G
    Biol Trace Elem Res; 1997 May; 57(2):131-7. PubMed ID: 9282260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological markers reflecting peripheral effects of thyroid hormones in autonomous thyroid adenoma].
    Földes J; Németh J; Bános C; Tarján G; Büki B
    Orv Hetil; 1991 Sep; 132(36):1983-5. PubMed ID: 1923470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency.
    Trifănescu R; Fica S; Barbu C; Vârtej I; Ursu H; Bunghez R; Coculescu M
    Rom J Intern Med; 2004; 42(3):595-605. PubMed ID: 16366133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical hyperthyroidism: controversies in management.
    Shrier DK; Burman KD
    Am Fam Physician; 2002 Feb; 65(3):431-8. PubMed ID: 11858626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum thyroxine and triiodothyronine responses of hyperthyroid cats to thyrotropin.
    Mooney CT; Thoday KL; Doxey DL
    Am J Vet Res; 1996 Jul; 57(7):987-91. PubMed ID: 8807008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between serum free thyroxine concentration and atrial fibrillation.
    Gammage MD; Parle JV; Holder RL; Roberts LM; Hobbs FD; Wilson S; Sheppard MC; Franklyn JA
    Arch Intern Med; 2007 May; 167(9):928-34. PubMed ID: 17502534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current issues in the treatment of thyrotoxicosis].
    Papi G
    Recenti Prog Med; 2005 Nov; 96(11):560-5. PubMed ID: 16499167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart rate variability and turbulence in hyperthyroidism before, during, and after treatment.
    Osman F; Franklyn JA; Daykin J; Chowdhary S; Holder RL; Sheppard MC; Gammage MD
    Am J Cardiol; 2004 Aug; 94(4):465-9. PubMed ID: 15325930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of trace elements in blood of thyroid disorder subjects before and after 131I therapy.
    Zhang F; Liu N; Wang X; Zhu L; Chai Z
    Biol Trace Elem Res; 2004 Feb; 97(2):125-34. PubMed ID: 14985623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of experimental hypo- and hyperthyroidism on serum adiponectin.
    Aragão CN; Souza LL; Cabanelas A; Oliveira KJ; Pazos-Moura CC
    Metabolism; 2007 Jan; 56(1):6-11. PubMed ID: 17161219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.